Annual Cash & Cash Equivalents
$3.60 M
-$18.73 M-83.90%
31 December 2023
Summary:
HCW Biologics annual cash & cash equivalents is currently $3.60 million, with the most recent change of -$18.73 million (-83.90%) on 31 December 2023. During the last 3 years, it has fallen by -$4.86 million (-57.48%). HCWB annual cash & cash equivalents is now -83.90% below its all-time high of $22.33 million, reached on 31 December 2022.HCWB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$998.20 K
-$163.10 K-14.04%
30 September 2024
Summary:
HCW Biologics quarterly cash and cash equivalents is currently $998.20 thousand, with the most recent change of -$163.10 thousand (-14.04%) on 30 September 2024. Over the past year, it has dropped by -$10.22 million (-91.10%). HCWB quarterly cash and cash equivalents is now -96.19% below its all-time high of $26.22 million, reached on 30 September 2022.HCWB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HCWB Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -83.9% | -91.1% |
| 3 y3 years | -57.5% | -93.4% |
| 5 y5 years | - | - |
HCWB Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.9% | at low | -96.2% | at low |
| 5 y | 5 years | -83.9% | at low | -96.2% | at low |
| alltime | all time | -83.9% | at low | -96.2% | at low |
HCW Biologics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $998.20 K(-14.0%) |
| June 2024 | - | $1.16 M(-71.6%) |
| Mar 2024 | - | $4.08 M(+13.6%) |
| Dec 2023 | $3.60 M(-83.9%) | $3.60 M(-68.0%) |
| Sept 2023 | - | $11.22 M(+50.6%) |
| June 2023 | - | $7.45 M(-59.5%) |
| Mar 2023 | - | $18.39 M(-17.6%) |
| Dec 2022 | $22.33 M | $22.33 M(-14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $26.22 M(+70.1%) |
| June 2022 | - | $15.42 M(-14.9%) |
| Mar 2022 | - | $18.12 M(+54.4%) |
| Dec 2021 | $11.73 M(+38.7%) | $11.73 M(-22.4%) |
| Sept 2021 | - | $15.13 M(+199.5%) |
| June 2021 | - | $5.05 M(-26.3%) |
| Mar 2021 | - | $6.86 M(-18.9%) |
| Dec 2020 | $8.46 M(+15.0%) | $8.46 M |
| Dec 2019 | $7.36 M | - |
FAQ
- What is HCW Biologics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for HCW Biologics?
- What is HCW Biologics annual cash & cash equivalents year-on-year change?
- What is HCW Biologics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for HCW Biologics?
- What is HCW Biologics quarterly cash and cash equivalents year-on-year change?
What is HCW Biologics annual cash & cash equivalents?
The current annual cash & cash equivalents of HCWB is $3.60 M
What is the all time high annual cash & cash equivalents for HCW Biologics?
HCW Biologics all-time high annual cash & cash equivalents is $22.33 M
What is HCW Biologics annual cash & cash equivalents year-on-year change?
Over the past year, HCWB annual cash & cash equivalents has changed by -$18.73 M (-83.90%)
What is HCW Biologics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HCWB is $998.20 K
What is the all time high quarterly cash and cash equivalents for HCW Biologics?
HCW Biologics all-time high quarterly cash and cash equivalents is $26.22 M
What is HCW Biologics quarterly cash and cash equivalents year-on-year change?
Over the past year, HCWB quarterly cash and cash equivalents has changed by -$10.22 M (-91.10%)